Patents by Inventor Anna SARNEFALT

Anna SARNEFALT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human monoclonal antibody
    Patent number: 9562105
    Abstract: The invention provides a method for the prophylaxis, improvement, or treatment of inflammatory bowel disease, multiple sclerosis, and psoriasis by administering to a subject an effective amount of an isolated anti-human CD81 antibody capable of binding to a peptide region consisting of the amino acid sequence of amino acid numbers 80 to 175 of SEQ ID NO:22.
    Type: Grant
    Filed: January 22, 2015
    Date of Patent: February 7, 2017
    Assignee: Sumitomo Dainippon Pharma Co., ltd.
    Inventors: Takamasa Watanabe, Tadahiko Yoshima, Mikael Mattsson, Anna Sarnefalt, Takuya Hasezaki
  • HUMAN MONOCLONAL ANTIBODY
    Publication number: 20150139990
    Abstract: The invention provides a method for the prophylaxis, improvement, or treatment of inflammatory bowel disease, multiple sclerosis, and psoriasis by administering to a subject an effective amount of an isolated anti-human CD81 antibody capable of binding to a peptide region consisting of the amino acid sequence of amino acid numbers 80 to 175 of SEQ ID NO:22.
    Type: Application
    Filed: January 22, 2015
    Publication date: May 21, 2015
    Inventors: Takamasa WATANABE, Tadahiko YOSHIMA, Mikael MATTSSON, Anna SARNEFALT, Takuya HASEZAKI
  • Human monoclonal antibody
    Patent number: 8940710
    Abstract: The present invention provides an anti-CD81 antibody usable as a pharmaceutical product for human. Specifically, the present invention provides an anti-human CD81 antibody capable of binding to a peptide region consisting of the amino acid sequence of the amino acid numbers 80 to 175 in the amino acid sequence shown in SEQ ID NO:22.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: January 27, 2015
    Assignee: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Takamasa Watanabe, Tadahiko Yoshima, Mikael Mattsson, Anna Sarnefalt, Takuya Hasezaki
  • Human monoclonal antibody
    Patent number: 8440797
    Abstract: The present invention provides an anti-CD81 antibody usable as a pharmaceutical product for human. Specifically, the present invention provides an anti-human CD81 antibody capable of binding to a peptide region consisting of the amino acid sequence of the amino acid numbers 80 to 175 in the amino acid sequence shown in SEQ ID NO:22.
    Type: Grant
    Filed: December 5, 2011
    Date of Patent: May 14, 2013
    Assignee: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Takamasa Watanabe, Tadahiko Yoshima, Mikael Mattsson, Anna Sarnefalt, Takuya Hasezaki
  • HUMAN MONOCLONAL ANTIBODY
    Publication number: 20120141486
    Abstract: The present invention provides an anti-CD81 antibody usable as a pharmaceutical product for human. Specifically, the present invention provides an anti-human CD81 antibody capable of binding to a peptide region consisting of the amino acid sequence of the amino acid numbers 80 to 175 in the amino acid sequence shown in SEQ ID NO:22.
    Type: Application
    Filed: December 5, 2011
    Publication date: June 7, 2012
    Applicant: DAINIPPON SUMITOMO PHARMA CO., LTD.
    Inventors: Takamasa WATANABE, Tadahiko YOSHIMA, Mikael MATTSSON, Anna SARNEFALT, Takuya HASEZAKI